Proteomic Plasma Analysis of Post-Vaccination Syndrome

A proteomic study analyzes plasma from 14 individuals with Post-Vaccination/Post-Infection Syndrome and 16 healthy controls. The research identifies significant alterations in coagulation factors, acute phase proteins, and immune response modulators. It was authored by Maxine Waters and published in 2026.

Use Cases

• Analyze elevated levels of serum amyloid A1 and A2 proteins in PV/PIS cohorts versus controls.
• Investigate dysregulation of coagulation factors X and XI to study coagulopathy signatures.
• Compare proteomic signatures of attractin and other immune modulators between PV/PIS and Long COVID.

Strengths

• Direct comparison of 14 PV/PIS cases against 16 matched healthy controls.
• Proteomic analysis conducted via liquid-chromatography-mass spectrometry.
• Results highlight distinct differences from prior Long COVID proteomic studies.
• Dataset is openly shared under a CC BY 4.0 license.

Limitations

• Small cohort size of 30 total participants limits statistical power.
• Data is presented in a PDF format (141.4 KB), not a structured, machine-readable table.
• Sample data and column definitions are unavailable for direct computational analysis.

Provenance

Source

figshare

Collection Method

Plasma proteomic analysis of digested microclot deposits from platelet-poor plasma samples using liquid-chromatography-mass spectrometry.

Time Range

null

Freshness

Last updated in March 2026.

Geography

null